The following services are covered under this chapter:

1. A. Office medical visits for the primary purpose of providing age and sex appropriate family planning services, which include:

   1. (1) Focused history, physical exam, and laboratory testing necessary to evaluate and manage the participant’s choice of chemical, mechanical, or other method to prevent conception;
   2. (2) Basic education regarding human sexuality and reproduction;
   3. (3) Advice and counseling regarding all family planning methods, including natural family planning measures and sterilization procedures, the availability and effectiveness of methods, procedures involved in each, and untoward effects and potential complications of each method; and
   4. (4) Referral mechanism and documented referral for all patients demonstrating illness, disease, or pregnancy;
2. B. Specimen collection by venipuncture or capillary puncture when performed by either the medical practitioner or the laboratory;
3. C. Pregnancy test if indicated by physical examination or history, or both, when performed by either the medical practitioner or the laboratory;

4. D. The following laboratory tests:

   1. (1) Hemoglobin or hematocrit, or both;
   2. (2) Urinalysis for albumin sugar;
   3. (3) Urine culture and sensitivity studies;
   4. (4) Appropriate laboratory tests to screen for sexually transmitted infections;
   5. (5) Smear wet mount and KOH with interpretation;
   6. (6) Rubella titer of females without documentation of prior rubella immunization; and
   7. (7) Pap smear;

5. E. Pharmaceutical supplies and devices:

   1. (1) To prevent conception through chemical, mechanical, or other methods, which are covered by the Maryland Medical Assistance Program under COMAR 10.09.03.04; and

   2. (2) To treat sexually transmitted infections when diagnosed during the course of an office visit, as outlined in §A of this regulation, which are covered under COMAR 10.09.03.04 except treatment for:

      1. (a) Human immunodeficiency virus; and
      2. (b) Hepatitis.

6. F. Permanent sterilization only when performed according to criteria in 42 CFR Part 441, Subpart F, Sterilizations, as amended, and when the appropriate forms are:

   1. (1) Properly completed; and
   2. (2) Available in the medical record for review;
7. G. Human papillomavirus vaccine; and
8. H. Abortions performed in accordance with Health-General Article, §15-103, Annotated Code of Maryland.

Authority: Health-General Article, §§2-104(b), 15-103, and 15-105, Annotated Code of Maryland

Effective date:

Regulations .01—.12 adopted as an emergency provision effective October 19, 1994 (21:23 Md. R. 1930); adopted permanently effective April 10, 1995 (22:7 Md. R. 536)

Regulation .01B, C amended as an emergency provision effective July 1, 2003 (30:17 Md. R. 1202); amended permanently effective October 13, 2003 (30:20 Md. R. 1448)

Regulation .01B, C amended effective January 12, 2009 (36:1 Md. R. 21)

Regulation .01 repealed and new Regulation .01 adopted as an emergency provision effective January 1, 2012 (39:2 Md. R. 139); adopted permanently effective June 11, 2012 (39:11 Md. R. 686)

Regulation .01B amended effective December 31, 2018 (45:26 Md. R. 1243)

Regulation .02B amended effective August 27, 2007 (34:17 Md. R. 1507)

Regulation .02B amended as an emergency provision effective January 1, 2012 (39:2 Md. R. 139); amended permanently effective June 11, 2012 (39:11 Md. R. 686)

Regulation .02B amended effective December 31, 2018 (45:26 Md. R. 1243)

Regulation .03 amended effective December 31, 2018 (45:26 Md. R. 1243)

Regulation .04 amended effective December 31, 2018 (45:26 Md. R. 1243)

Regulation .04D adopted as an emergency provision effective January 1, 2012 (39:2 Md. R. 139); amended permanently effective June 11, 2012 (39:11 Md. R. 686)

Regulation .05A, D, E amended effective December 31, 2018 (45:26 Md. R. 1243)

Regulation .05F amended effective January 12, 2009 (36:1 Md. R. 21); March 31, 2025 (52:6 Md. R. 267)

Regulation .05F amended as an emergency provision effective January 1, 2012 (39:2 Md. R. 139); amended permanently effective June 11, 2012 (39:11 Md. R. 686)

Regulation .05G amended effective March 31, 2025 (52:6 Md. R. 267)

Regulation .05H adopted effective March 31, 2025 (52:6 Md. R. 267)

Regulation .06 amended effective December 31, 2018 (45:26 Md. R. 1243)

Regulation .06A amended effective August 27, 2007 (34:17 Md. R. 1507); March 31, 2025 (52:6 Md. R. 267)

Regulation .06A amended as an emergency provision effective January 1, 2012 (39:2 Md. R. 139); amended permanently effective June 11, 2012 (39:11 Md. R. 686)

Regulation .07 amended effective June 11, 2012 (39:11 Md. R. 686); December 31, 2018 (45:26 Md. R. 1243)

Regulation .10 repealed and new Regulation .10 adopted as an emergency provision effective January 1, 2012 (39:2 Md. R. 139); adopted permanently effective June 11, 2012 (39:11 Md. R. 686)